Beauty Garage Inc. reported a decline in annual net profit to 913 million yen for the fiscal year ending April 30, 2026, down from 1.02 billion yen in the previous year. Despite the bottom-line dip, the Tokyo-listed company saw its annual revenue grow to 38.20 billion yen, up from 33.72 billion yen.
Heiwado Co. Ltd. reported a sharp decline in first-quarter net profit to 1.19 billion yen, nearly halving from the 2.17 billion yen recorded during the same period last year. Despite a modest increase in top-line revenue, mounting operational pressures weighed heavily on the Japanese retailer’s bottom line for the three months ended May 20.
DVx Inc. closed its 2026 fiscal year on March 31 with a net profit of 225 million yen, according to the company's latest financial disclosure. The Tokyo-listed firm, operating under Japanese accounting standards, generated 55.99 billion yen in total revenue throughout the twelve-month period ending this spring.
A stellar earnings report from U.S. chipmaker Micron has reignited investor appetite for artificial intelligence hardware, triggering a sharp rally in South Korean semiconductor giants. SK Hynix shares jumped 12% on U.S. listing plans, while Samsung climbed 6.2% following news of a potential massive share buyback program.
A 9.4% plunge in Trip.com Group’s Hong Kong-listed shares on Thursday signaled investor anxiety, as the online travel giant reported a 7% dip in adjusted net profit. Despite a 17% revenue climb to $2.4 billion, the company’s outlook for the second quarter points toward a sharp slowdown in expansion.
Unexpected strength in the labor market emerged this May as Australia’s jobless rate ticked down to 4.4% from 4.5%. Despite the central bank’s aggressive interest-rate hikes designed to cool inflationary pressure, employers added 40,300 positions, significantly outpacing the 32,000 jobs analysts had projected for the month.
A $3.8 million payment default has triggered the collapse of a key partnership for Apollomics, forcing the biopharmaceutical firm to terminate its licensing deal with Launxp International. The move effectively restores the company’s full global control over its lead clinical asset, vebreltinib, outside of mainland China and Macau.
Crude oil futures tumbled 3.9% to $70.34 a barrel today, marking the lowest price point since February 27. This sharp decline in energy markets triggered a broader sell-off in oil company shares, reflecting investor anxiety as the commodity market retreats to levels last seen before the outbreak of conflict in Iran.
Following the successful completion of the Federal Reserve’s annual stress test, U.S. Bancorp has increased its quarterly dividend by 3.8%. The board’s decision, which elevates the payout to 54 cents per share, signals confidence in the Minneapolis-based lender’s capacity to endure significant economic volatility in the coming fiscal cycle.
A 6.5% reduction in water rates is coming to the most populated districts of Grand Cayman, following a new 25-year operating license granted to Cayman Water Company Limited. The agreement, issued by the island's utility regulator, establishes a refreshed regulatory framework for water distribution across Seven Mile Beach and West Bay.
The U.S. dollar surged to a 13-month high on Wednesday, triggering a sharp sell-off across raw material markets and precious metals. This reversal marks a painful pivot for investors who spent the better part of 2026 betting against the greenback, leaving gold and silver prices reeling from their earlier record peaks.
Traders shifted capital into undervalued health-care stocks this week, lifting the sector as biotech giant Gilead Sciences secured a significant regulatory victory. The FDA authorized the company’s drug Trodelvy for newly diagnosed patients battling triple-negative breast cancer, a particularly aggressive form of the disease that often resists standard treatment protocols.
Industrial and transportation shares climbed as investor anxiety over inflation began to recede. While the broader sector enjoyed a lift, the defense industry faced a sharp pivot in German procurement strategy that sent shares of Rheinmetall into a tailspin following the cancellation of a major naval contract.
Consumer stocks climbed Wednesday as U.S. jet fuel prices tumbled to $2.81 a gallon, their lowest point since the onset of the conflict in Iran this February. With energy costs receding toward late-winter lows, investors pivoted back into the travel sector, pushing the U.S. Global Jets ETF up more than 3.5%.
A retreat in private-credit shares dragged down the broader financial sector today, as market anxiety over lending standards eclipsed recent optimism surrounding commercial and mortgage banking gains. Investors signaled growing unease, pushing major industry players into a sharp decline that underscored the sector's sensitivity to credit risk.
A 23% plunge in after-hours trading greeted ARS Pharmaceuticals on Wednesday, as the company revealed that its needle-free epinephrine nasal spray, Neffy, failed to secure new commercial insurance coverage during the current cycle. The sharp decline erased earlier gains, leaving investors rattled by the lack of formulary expansion.
Investors rotated out of technology stocks Tuesday, sparking a broad sector slide even as individual earnings reports offered a complex picture of the industry’s health. While market enthusiasm for artificial intelligence remains high, the inconsistency between explosive gains and sudden sell-offs suggests a more cautious approach to chip-related equities.
A broad retreat from high-risk market segments dragged communications-services stocks lower, as investors recalibrated their exposure to the technology sector. Netflix shares led the slide, deepening their year-to-date decline beyond 20 percent and reflecting a wider cooling of sentiment toward previously high-flying digital growth assets.
Power producers saw a broad lift in share prices today as market participants retreated from high-growth tech stocks, favoring the stability of the utilities sector. This rotation into safe havens underscores a growing preference for defensive assets amid the persistent price swings currently rattling broader equity markets.
Investors reacted sharply to an all-stock merger between Passage Bio and Remix Therapeutics, sending the former’s shares down 16% to $4.93 in after-hours trading. The consolidation marks a pivot for Passage Bio, which has seen its stock value halve over the course of the year amid regulatory hurdles.
A 14% jump in after-hours trading greeted Methode Electronics on Wednesday after the company soundly beat quarterly revenue expectations. With shares already up 97% year to date, the manufacturer pivoted from a significant year-ago loss to a positive fiscal fourth quarter, signaling a turnaround in its core segments.
A surge in American demand for British-made cars drove a 2.7% rise in U.K. vehicle manufacturing last May, as production lines output 51,178 units. This modest recovery marks a rebound from the previous year’s slump, which was hampered by heightened tariff uncertainty across the Atlantic.
Spok Holdings will divest a portion of its narrowband spectrum portfolio to Sensus USA in an $8 million transaction. The agreement, expected to finalize in the third quarter, allows the Plano-based healthcare communications firm to streamline its network infrastructure as demand for traditional two-way paging services continues to decline.
Facing a surge in overhead, Oil-Dri Corporation will increase prices across its specialty sorbent product line early in fiscal year 2027. The manufacturer, squeezed by rising expenditures in freight, resin-based packaging, and employee health insurance, signaled that the adjustment is essential to preserve service standards and product quality.
A $48.7 million quarterly loss has eclipsed Worthington Steel’s revenue growth, as the Columbus-based processor grapples with significant impairment charges within its Electrical Steel unit. The shift from last year’s $55.7 million profit underscores the financial friction caused by recent expansion efforts and asset write-downs.
A strategic national security agency in the Asia-Pacific region has finalized a $5 million agreement with Israeli software firm Cognyte. The deal focuses on modernizing network intelligence infrastructure, positioning the government client to integrate advanced AI-driven analytics as data volumes and security threats continue to escalate.
State Street plans a 10% hike to its quarterly dividend, raising the payout to 92 cents per share from 84 cents. This decision follows the firm's successful performance in the Federal Reserve's annual stress test, which evaluated the ability of major financial institutions to withstand severe economic volatility.
A 57% revenue spike in the investment banking division propelled Jefferies Financial Group to a $226.2 million profit for the fiscal second quarter. The firm’s earnings reached $1.02 per share, significantly outpacing the $88 million reported during the same period last year as corporate dealmaking activity rebounded.
MillerKnoll swung to a $23.6 million profit in its fiscal fourth quarter, overcoming earlier warnings that regional instability and rising logistics costs might hamper performance. The office-furniture manufacturer outperformed Wall Street expectations, bolstered by a 4.4% revenue increase that pushed total quarterly sales to $1 billion.
Morgan Stanley is tightening its grip on shareholder loyalty, announcing a 15% dividend hike alongside a fresh $20 billion share repurchase program. The move, set to begin in the third quarter, signals confidence in the firm’s capital position even as it navigates a volatile financial landscape.
